IFGL Refractories Limited (NSE:IFGLEXPOR)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	15,888	12,598	19,582	7,548	9,296	11,313
Market Cap Growth	-19.47%	-35.67%	159.42%	-18.80%	-17.82%	246.47%
Enterprise Value	16,476	12,741	19,691	6,861	7,574	9,437
Last Close Price	220.43	172.07	264.43	100.48	120.52	142.93
PE Ratio	54.53	29.31	23.98	9.53	12.00	17.25
Forward PE	14.13	8.26	8.26	8.26	8.26	8.26
PS Ratio	0.94	0.76	1.19	0.54	0.74	1.11
PB Ratio	1.44	1.14	1.83	0.75	1.00	1.27
P/TBV Ratio	1.69	1.34	2.22	0.96	1.30	1.76
P/FCF Ratio	-	-	112.21	-	-	10.45
P/OCF Ratio	-	44.55	12.87	119.86	212.64	8.12
PEG Ratio	-	0.22	0.22	0.22	0.22	0.22
EV/Sales Ratio	0.97	0.77	1.20	0.50	0.60	0.92
EV/EBITDA Ratio	13.51	9.73	12.86	4.56	5.42	6.10
EV/EBIT Ratio	22.16	14.72	16.80	5.52	6.40	6.99
EV/FCF Ratio	-	-	112.84	-	-	8.71
Debt / Equity Ratio	0.19	0.19	0.16	0.16	0.11	0.07
Debt / EBITDA Ratio	1.75	1.61	1.13	1.05	0.70	0.41
Debt / FCF Ratio	-	-	9.98	-	-	0.59
Asset Turnover	-	1.06	1.12	1.02	1.02	0.92
Inventory Turnover	-	2.41	2.83	2.64	2.95	3.14
Quick Ratio	-	1.24	1.64	1.68	1.83	2.40
Current Ratio	-	2.28	2.68	2.71	2.82	3.22
Return on Equity (ROE)	-	3.94%	7.86%	8.17%	8.49%	7.72%
Return on Assets (ROA)	-	3.48%	5.02%	5.73%	5.99%	7.62%
Return on Capital (ROIC)	3.62%	4.22%	6.08%	7.07%	7.44%	9.23%
Return on Capital Employed (ROCE)	-	7.20%	10.00%	11.10%	11.80%	14.10%
Earnings Yield	1.83%	3.41%	4.17%	10.49%	8.33%	5.80%
FCF Yield	-	-3.54%	0.89%	-17.26%	-6.64%	9.57%
Dividend Yield	1.59%	2.03%	1.32%	3.48%	2.90%	1.40%
Payout Ratio	-	58.70%	30.89%	31.85%	46.51%	-
Buyback Yield / Dilution	-0.02%	-	-	-	-	-
Total Shareholder Return	1.52%	2.03%	1.32%	3.48%	2.90%	1.40%

Updated Feb 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.